LLY

1,010.29

-0.77%↓

JNJ

247.77

-0.21%↓

ABBV

235.04

+0.67%↑

NVS

164.41

-1.49%↓

MRK

120.52

-0.8%↓

LLY

1,010.29

-0.77%↓

JNJ

247.77

-0.21%↓

ABBV

235.04

+0.67%↑

NVS

164.41

-1.49%↓

MRK

120.52

-0.8%↓

LLY

1,010.29

-0.77%↓

JNJ

247.77

-0.21%↓

ABBV

235.04

+0.67%↑

NVS

164.41

-1.49%↓

MRK

120.52

-0.8%↓

LLY

1,010.29

-0.77%↓

JNJ

247.77

-0.21%↓

ABBV

235.04

+0.67%↑

NVS

164.41

-1.49%↓

MRK

120.52

-0.8%↓

LLY

1,010.29

-0.77%↓

JNJ

247.77

-0.21%↓

ABBV

235.04

+0.67%↑

NVS

164.41

-1.49%↓

MRK

120.52

-0.8%↓

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Open

SectorGezondheidszorg

18.19 0.83

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.99

Max

18.92

Belangrijke statistieken
By Trading Economics
Inkomsten	2M -17M
Verkoop	178K 264K
EPS	-0.29
Winstmarge	-6,603.409
Werknemers	116
EBITDA	-2M -21M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+59.15% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	17.36
Vorige sluitingsprijs	18.19

Nieuwssentiment

By Acuity

56%

44%

286 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 mrt 2026, 23:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2 mrt 2026, 23:37 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2 mrt 2026, 23:26 UTC

Belangrijke Nieuwsgebeurtenissen

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2 mrt 2026, 22:41 UTC

Marktinformatie

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2 mrt 2026, 22:32 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

2 mrt 2026, 22:32 UTC

Marktinformatie

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2 mrt 2026, 22:21 UTC

Marktinformatie

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2 mrt 2026, 22:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

2 mrt 2026, 22:11 UTC

Marktinformatie

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2 mrt 2026, 22:10 UTC

Acquisities, Fusies, Overnames

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2 mrt 2026, 22:06 UTC

Marktinformatie

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2 mrt 2026, 22:00 UTC

Marktinformatie

Winsten

Global Forex and Fixed Income Roundup: Market Talk

2 mrt 2026, 22:00 UTC

Marktinformatie

Winsten

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2 mrt 2026, 21:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Energy & Utilities Roundup: Market Talk

2 mrt 2026, 21:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

2 mrt 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

2 mrt 2026, 21:35 UTC

Acquisities, Fusies, Overnames

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2 mrt 2026, 21:34 UTC

Acquisities, Fusies, Overnames

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2 mrt 2026, 21:30 UTC

Acquisities, Fusies, Overnames

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mrt 2026, 21:17 UTC

Belangrijke Nieuwsgebeurtenissen

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2 mrt 2026, 20:44 UTC

Winsten

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mrt 2026, 20:43 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Treasury Yields Rise, Dollar Strengthens After Attack on Iran -- Market Talk

2 mrt 2026, 20:28 UTC

Winsten

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2 mrt 2026, 20:25 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2 mrt 2026, 20:24 UTC

Winsten

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mrt 2026, 20:14 UTC

Acquisities, Fusies, Overnames

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mrt 2026, 20:12 UTC

Belangrijke Nieuwsgebeurtenissen

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2 mrt 2026, 20:08 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Forex and Fixed Income Roundup: Market Talk

2 mrt 2026, 20:08 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2 mrt 2026, 20:05 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

59.15% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 30 USD 59.15%

Hoogste 30 USD

Laagste 30 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

286 / 352 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.